Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03 [0.03%]
BrainChild-03试验中儿童弥漫性内生性桥脑胶质瘤接受B7-H3靶向CAR-T细胞治疗相关的肿瘤炎症性神经毒性反应
Rebecca Ronsley,Michelle Choe,Jason Wright et al.
Rebecca Ronsley et al.
Background: Chimeric antigen receptor (CAR) T cell therapy is a promising treatment for central nervous system (CNS) tumors like diffuse intrinsic pontine glioma (DIPG) and diffuse midline glioma (DMG). Unlike systemic ad...
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases [0.03%]
Vorasidenib无应答者中保留的IDH突变和甲基化类型:2例报道
Mehdi Touat,Jacqueline Lehmann-Che,Salah Eddine O Kacimi et al.
Mehdi Touat et al.
Background: The INDIGO trial recently showed that vorasidenib improves progression-free survival in patients with grade 2 IDH-mutated glioma. However, 20%-25% of patients experienced disease progression within the first y...
Neurogenetic tumor syndromes: The current landscape of workup and treatment [0.03%]
神经遗传性肿瘤综合征:目前的诊断和治疗现状
Rimas V Lukas,Ashley Cannon,Prashant Chittiboina et al.
Rimas V Lukas et al.
Experts and generalists from numerous clinical disciplines are likely to encounter and be involved in the care of patients with neurogenetic tumor syndromes. Considerations for genetic testing are discussed. Specific conditions including ne...
Health-related quality of life outcomes of surgery for diffuse glioma: A systematic review and pooled analysis [0.03%]
弥漫性胶质瘤手术的健康相关生活质量结果:系统评价和汇总分析
Yash Akkara,Ryan Afreen,Raymund L Yong
Yash Akkara
Background: Although progress has been made in understanding the effects of adjuvant therapy on health-related quality of life (HR-QoL) in diffuse glioma patients, less is known about the impact of surgical resection. To ...
Patient and caregiver experiences with selumetinib for the treatment of pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas [0.03%]
关于索拉非尼治疗I型神经纤维瘤病患者的肢神经鞘瘤的患者及看护者经历
Julia Meade,Michael Blackowicz,Ayo Adeyemi et al.
Julia Meade et al.
Background: Plexiform neurofibromas (PN) affect 20%-50% of patients with neurofibromatosis type 1 (NF1) and can lead to pain, disfigurement, motor dysfunction, compression of vital structures, and risk of malignant degene...
Risk of central nervous system metastasis and survival in HER2+ positive breast and non-breast cancers [0.03%]
HER2阳性乳腺癌和非乳腺癌患者中枢神经系统转移的风险及生存分析
Omar Elghawy,John S Wang,Reema Patel et al.
Omar Elghawy et al.
Background: Incidence, survival, and optimal choice of therapy for central nervous system (CNS) metastasis are well characterized in human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC), yet remain...
Opportunities and challenges in application of VASARI features in neuro-oncology [0.03%]
VASARI在神经肿瘤学中应用的机会与挑战
Maria Golebiowska,Sun Mo Nam,Jong Ha Hwang et al.
Maria Golebiowska et al.
The application of objective radiological data in glioma research remains an underexplored opportunity in neuro-oncology. Despite multiple efforts to incorporate radiomic features in glioma analysis, the lack of a unified imaging reporting ...
From discovery to delivery: the spectrum of decisional supports for people with brain tumors [0.03%]
从发现到治疗:脑肿瘤患者决策支持的范围
Caroline Crooms,Heather E Leeper
Caroline Crooms
A scoping review: Understanding brain tumor patients' decisional needs and preferences [0.03%]
一项范围性综述:了解脑肿瘤患者的选择需求和喜好
Iris J M Bras,Petra Hoogendoorn,Margriet M Sitskoorn et al.
Iris J M Bras et al.
Background: Informed, value-based healthcare decisions depend on individuals' decisional needs and preferences. Adequately addressing them may improve decision experience and quality. This scoping review aims to assess st...
Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classification [0.03%]
根据2021年CNS WHO五版分类展示弥漫性胶质瘤分子亚型的临床和影像学特点
Jasmin Jo,Mark Willy L Mondia,Josephine Arewa et al.
Jasmin Jo et al.
Background: The incorporation of molecular parameters into WHO CNS5 has led to reclassification of gliomas. We describe presenting clinical and radiographic features of diffuse adult gliomas according to CNS5 category. ...